An economic model of the long-term health care burden of Type II diabetes

Diabetologia

Volumn 44, Issue 12, 2001, Pages 2140-2155

  Bagust, A ^a   Hopkinson, P K ^b   Maier, W ^c   Currie, C J ^d  

^a UNIVERSITY OF YORK   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Economic model; Epidemiology; Health care costs; Type II diabetes

Indexed keywords

ADULT; AGED; ARTICLE; BUDGET; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; LIFESPAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; POPULATION STRUCTURE; PRIORITY JOURNAL; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; LONGEVITY; MALE; MIDDLE AGED; MODELS, ECONOMIC; MORBIDITY; TIME FACTORS;

EID: 0035678809     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100023     Document Type: Article

References (49)

1. The rising global burden of diabetes and its complications: Estimates and projections to Year 2010
2. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 yr
3. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis
4. Quality of life and associated characteristics in a large national sample of adults with diabetes
5. The costs of non-insulin-dependent diabetes mellitus
6. Chronic renal failure in non-insulin-dependent diabetes mellitus: A population-based study in Rochester, Minnesota
7. Hyperglycaemia and microvascular and macrovascular disease in diabetes
8. Macrovascular disease and hyperglycaemia: 10-Year survival analysis in Type II diabetes mellitus: The Belfast diet study
9. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
10. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent mellitus: A randomized prospective 6-year study
11. The association of glycemia and cause-specific mortality in a diabetic population
12. Diabetes mellitus and macrovascular complications. An epidemiological perspective
13. Albuminuria and poor glycemic control predict mortality in NIDDM
14. The insulin resistance syndrome (syndrome X) and risk factors for coronary heart disease
15. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: How sweet it is ... or is it?
16. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians
17. The ten-year follow-up of the Bedford survey (1962-1972): Glucose tolerance and diabetes
18. Insulin resistance and insulin deficiency in the pathogenesis of Type II (non-insulin-dependent) diabetes mellitus: Errors of metabolism or of methods?
19. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: Implications for the management of diabetes
20. Model of complications of NIDDM. I. Model construction and assumptions
21. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycaemia
22. Outline of a diabetes disease management model: Principles and applications
23. The global diabetes model: User friendly version 3.0
24. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
25. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
26. The prevalence of multiple diabetes-related complications
27. Mortality in non-insulin-dependent diabetes
28. Diabetes asymptomatic hyperglycaemia and 22-year mortality in black and white men
29. Detecting and treating retinopathy in patients with type 1 diabetes mellitus
30. Microalbuminuria a predictor of proteinuria and early mortality in NIDDM
31. UKPDS VIII: Study design, progress and performance
32. Late sequelae of diabetic neuropathy
33. Starting insulin therapy in type 2 diabetes: Effectiveness, complications and resource utilization
34. Population by ethnic group and age, 1998-99
35. The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy and ulceration in diabetes
36. Relative activity and referral patterns for diabetes and non-diabetes in general practice
37. Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing
38. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40
39. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: Economic analysis alongside randomised controlled trial (UKPDS 41)
40. Independent predictors of quality of life in type 2 diabetes: The CODE-2 Experience
41. Type 2 diabetes impact on quality-adjusted life expectancy
42. The Mt. Hood challenge: Cross-testing two diabetes simulation models
43. Cardiovascular disease risk profiles